Long term use of PPIs is also associated with an increased risk of gastric cancer, with one possible explanation attributed to elevated levels of gastrin and alterations in the microbiome (Arai et al., 2024; Hayakawa et al., 2016). The gene discussed is GAST; the disease is gastric cancer.